• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高危型人乳头瘤病毒致癌基因 E6 和 E7 靶向关键细胞通路以实现癌变。

High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis.

机构信息

Cancer Science Institute of Singapore, National University of Singapore, Singapore 117599, Singapore.

NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore 117456, Singapore.

出版信息

Int J Mol Sci. 2018 Jun 8;19(6):1706. doi: 10.3390/ijms19061706.

DOI:10.3390/ijms19061706
PMID:29890655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6032416/
Abstract

Infection with high-risk human papillomavirus (HPV) has been linked to several human cancers, the most prominent of which is cervical cancer. The integration of the viral genome into the host genome is one of the manners in which the viral oncogenes E6 and E7 achieve persistent expression. The most well-studied cellular targets of the viral oncogenes E6 and E7 are p53 and pRb, respectively. However, recent research has demonstrated the ability of these two viral factors to target many more cellular factors, including proteins which regulate epigenetic marks and splicing changes in the cell. These have the ability to exert a global change, which eventually culminates to uncontrolled proliferation and carcinogenesis.

摘要

高危型人乳头瘤病毒(HPV)感染与多种人类癌症有关,其中最突出的是宫颈癌。病毒基因组整合到宿主基因组中是病毒癌基因 E6 和 E7 实现持续表达的方式之一。病毒癌基因 E6 和 E7 最受研究关注的细胞靶标分别是 p53 和 pRb。然而,最近的研究表明,这两种病毒因子能够靶向许多更多的细胞因子,包括调节细胞表观遗传标记和剪接变化的蛋白质。这些因子能够发挥全局变化,最终导致不受控制的增殖和癌变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbe/6032416/58c198721fca/ijms-19-01706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbe/6032416/9d3543596302/ijms-19-01706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbe/6032416/5d699dff5ed1/ijms-19-01706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbe/6032416/58c198721fca/ijms-19-01706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbe/6032416/9d3543596302/ijms-19-01706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbe/6032416/5d699dff5ed1/ijms-19-01706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfbe/6032416/58c198721fca/ijms-19-01706-g003.jpg

相似文献

1
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis.高危型人乳头瘤病毒致癌基因 E6 和 E7 靶向关键细胞通路以实现癌变。
Int J Mol Sci. 2018 Jun 8;19(6):1706. doi: 10.3390/ijms19061706.
2
High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.高危α乳头瘤病毒癌基因损害同源重组途径。
J Virol. 2017 Sep 27;91(20). doi: 10.1128/JVI.01084-17. Print 2017 Oct 15.
3
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets.HPV E6/E7 致癌基因:病毒致癌的关键因素和治疗靶点。
Trends Microbiol. 2018 Feb;26(2):158-168. doi: 10.1016/j.tim.2017.07.007. Epub 2017 Aug 17.
4
Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.人乳头瘤病毒致癌基因在HeLa宫颈癌细胞中的抑制会导致休眠的肿瘤抑制途径有序重新激活。
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12513-8. doi: 10.1073/pnas.97.23.12513.
5
Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.慢病毒载体介导靶向 HPV16 E6 和 E7 癌基因共同启动子的 shRNA 抑制宫颈癌细胞体外和体内生长。
Antiviral Res. 2013 May;98(2):305-13. doi: 10.1016/j.antiviral.2013.03.010. Epub 2013 Mar 21.
6
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.转录激活样效应因子核酸酶(TALEN)介导的人乳头瘤病毒(HPV)致癌基因靶向作用可改善HPV相关的宫颈恶性肿瘤。
J Clin Invest. 2015 Jan;125(1):425-36. doi: 10.1172/JCI78206. Epub 2014 Dec 15.
7
Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.人乳头瘤病毒31型E6和E7癌蛋白序列变异的系统发育和功能分析
Infect Genet Evol. 2016 Sep;43:94-100. doi: 10.1016/j.meegid.2016.05.020. Epub 2016 May 16.
8
HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.人乳头瘤病毒16型癌基因E6或/和E7可能影响宫颈癌细胞系HT-3中RASSFIA基因启动子区域的甲基化状态。
Oncol Rep. 2017 Apr;37(4):2324-2334. doi: 10.3892/or.2017.5465. Epub 2017 Feb 17.
9
Wogonin induces apoptosis by suppressing E6 and E7 expressions and activating intrinsic signaling pathways in HPV-16 cervical cancer cells.Wogonin 通过抑制 HPV-16 宫颈癌细胞中的 E6 和 E7 表达并激活内在信号通路诱导细胞凋亡。
Cell Biol Toxicol. 2013 Aug;29(4):259-72. doi: 10.1007/s10565-013-9251-4. Epub 2013 Aug 18.
10
Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.16型乳头瘤病毒致癌基因可下调宫颈角质形成细胞中干扰素反应基因的表达,并上调增殖相关基因和NF-κB反应基因的表达。
J Virol. 2001 May;75(9):4283-96. doi: 10.1128/JVI.75.9.4283-4296.2001.

引用本文的文献

1
Integrating bioinformatics to explore HPV-31 and HPV-52 E6/E7 proteins: from structural analysis to antigenic epitope prediction.整合生物信息学以探索人乳头瘤病毒31型和人乳头瘤病毒52型E6/E7蛋白:从结构分析到抗原表位预测
Front Immunol. 2025 Jul 25;16:1561572. doi: 10.3389/fimmu.2025.1561572. eCollection 2025.
2
Revolutionizing cervical cancer treatment: single-cell sequencing of tumor EPCs and immune checkpoints to assess drug sensitivity and optimize therapy.变革宫颈癌治疗:肿瘤内皮祖细胞和免疫检查点的单细胞测序以评估药物敏感性并优化治疗
Front Immunol. 2025 Jul 24;16:1574174. doi: 10.3389/fimmu.2025.1574174. eCollection 2025.
3

本文引用的文献

1
Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer.摩洛哥乳腺癌患者黏膜和皮肤人乳头瘤病毒的患病率
Papillomavirus Res. 2018 Jun;5:150-155. doi: 10.1016/j.pvr.2018.04.003. Epub 2018 Apr 13.
2
HPV Status and Its Correlation with BCL2, p21, p53, Rb, and Survivin Expression in Breast Cancer in a Chinese Population.中国人乳腺癌中 HPV 状态及其与 BCL2、p21、p53、Rb 和 Survivin 表达的相关性。
Biomed Res Int. 2017;2017:6315392. doi: 10.1155/2017/6315392. Epub 2017 Dec 20.
3
Viral infections and breast cancer - A current perspective.
Prevalence and Genotype Distribution of Human Papillomavirus Among Males in Shantou, China (2019-2023).
中国汕头男性人乳头瘤病毒的流行率和基因型分布(2019 - 2023年)
Health Sci Rep. 2025 Jul 18;8(7):e71094. doi: 10.1002/hsr2.71094. eCollection 2025 Jul.
4
The role of pioneering transcription factors, chromatin accessibility and epigenetic reprogramming in oncogenic viruses.先驱转录因子、染色质可及性和表观遗传重编程在致癌病毒中的作用。
Front Microbiol. 2025 Jun 16;16:1602497. doi: 10.3389/fmicb.2025.1602497. eCollection 2025.
5
HPV-driven cancers: a looming threat and the potential of CRISPR/Cas9 for targeted therapy.人乳头瘤病毒驱动的癌症:一个迫在眉睫的威胁以及CRISPR/Cas9用于靶向治疗的潜力
Virol J. 2025 May 22;22(1):156. doi: 10.1186/s12985-025-02783-x.
6
Pre-invasive Lesion of Cervix Among Healthy and Immune Compromised Individuals Using Histopathological Examination: A Hospital Based Cross-Sectional Study.使用组织病理学检查对健康和免疫功能低下个体宫颈的癌前病变进行研究:一项基于医院的横断面研究
J Obstet Gynaecol India. 2025 Apr;75(Suppl 1):106-112. doi: 10.1007/s13224-024-02017-0. Epub 2024 Jun 27.
7
Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy.组蛋白去乙酰化酶抑制与细胞因子联合应用可增强治疗性人乳头瘤病毒疫苗疗法。
J Immunother Cancer. 2025 May 2;13(5):e011074. doi: 10.1136/jitc-2024-011074.
8
Human Papillomavirus: A Narrative Review for Dental Providers in Prevention and Care.人乳头瘤病毒:面向牙科从业者的预防与护理综述
Int J Environ Res Public Health. 2025 Mar 17;22(3):439. doi: 10.3390/ijerph22030439.
9
Screening and identification analysis of core markers for leukemia and cervical cancer: Calmodulin 3 as a core target.白血病和宫颈癌核心标志物的筛选与鉴定分析:钙调蛋白3作为核心靶点
Medicine (Baltimore). 2025 Apr 4;104(14):e41665. doi: 10.1097/MD.0000000000041665.
10
Revealing the viral culprits: the hidden role of the oral virome in head and neck cancers.揭示病毒元凶:口腔病毒组在头颈癌中的隐藏作用。
Arch Microbiol. 2025 Feb 28;207(4):73. doi: 10.1007/s00203-025-04270-x.
病毒感染与乳腺癌——当前视角。
Cancer Lett. 2018 Apr 28;420:182-189. doi: 10.1016/j.canlet.2018.01.076. Epub 2018 Feb 21.
4
Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV).致癌病毒与乳腺癌:小鼠乳腺肿瘤病毒(MMTV)、牛白血病病毒(BLV)、人乳头瘤病毒(HPV)和爱泼斯坦-巴尔病毒(EBV)。
Front Oncol. 2018 Jan 22;8:1. doi: 10.3389/fonc.2018.00001. eCollection 2018.
5
Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.人乳头瘤病毒16 E7通过抑制Cullin 2依赖性蛋白降解来稳定载脂蛋白B mRNA编辑酶催化多肽样3A(APOBEC3A)蛋白。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.01318-17. Print 2018 Apr 1.
6
Human papillomavirus type 18 E5 oncogene supports cell cycle progression and impairs epithelial differentiation by modulating growth factor receptor signalling during the virus life cycle.人乳头瘤病毒18型E5癌基因在病毒生命周期中通过调节生长因子受体信号传导来支持细胞周期进程并损害上皮分化。
Oncotarget. 2017 Oct 6;8(61):103581-103600. doi: 10.18632/oncotarget.21658. eCollection 2017 Nov 28.
7
Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation.人乳头瘤病毒E6与Myc直接相互作用可诱导组蛋白修饰、RNA聚合酶II磷酸化以及端粒酶逆转录酶启动子激活。
Oncotarget. 2017 Oct 25;8(56):96323-96339. doi: 10.18632/oncotarget.22036. eCollection 2017 Nov 10.
8
Human Papillomavirus and Oropharyngeal Cancer.人乳头瘤病毒与口咽癌
Dent Clin North Am. 2018 Jan;62(1):111-120. doi: 10.1016/j.cden.2017.08.008. Epub 2017 Oct 7.
9
TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter.TIP60通过抑制Sp1与端粒酶逆转录酶(TERT)启动子的结合来抑制端粒酶表达。
PLoS Pathog. 2017 Oct 18;13(10):e1006681. doi: 10.1371/journal.ppat.1006681. eCollection 2017 Oct.
10
Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.载脂蛋白B编辑酶催化多肽样3A和3B在人乳头瘤病毒感染及疾病进展中的作用
Viruses. 2017 Aug 21;9(8):233. doi: 10.3390/v9080233.